I agree that this site is using cookies. You can find further informations here.
X
Tähtinen, Siri
55  results:
Search for persons X
?
1

Progress in vaccine development for infectious diseases—a K..:

Cable, Jennifer ; Graham, Barney S. ; Koup, Richard A....
Annals of the New York Academy of Sciences.  1524 (2023)  1 - p. 65-86 , 2023
Link: https://doi.org/10.1111/..
 
?
2

IL-1 and IL-1ra are key regulators of the inflammatory resp..:

Tahtinen, Siri ; Tong, Ann-Jay ; Himmels, Patricia...
Nature Immunology.  23 (2022)  4 - p. 532-542 , 2022
Link: https://doi.org/10.1038/..
 
?
3

Oncolytic adenovirus decreases the proportion of TIM-3+ sub..:

Liikanen, Ilkka ; Basnet, Saru ; Quixabeira, Dafne C A...
Journal for ImmunoTherapy of Cancer.  10 (2022)  2 - p. e003490 , 2022
Link: https://doi.org/10.1136/..
 
?
4

Dexamethasone premedication suppresses vaccine-induced immu..:

Vormehr, Mathias ; Lehar, Sophie ; Kranz, Lena M....
OncoImmunology.  9 (2020)  1 - p. , 2020
Link: https://doi.org/10.1080/..
 
?
5

Artificially cloaked viral nanovaccine for cancer immunothe..:

Fusciello, Manlio ; Fontana, Flavia ; Tähtinen, Siri...
Nature Communications.  10 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
6

Interleukin 8 activity influences the efficacy of adenovira..:

Taipale, Kristian ; Tähtinen, Siri ; Havunen, Riikka...
Oncotarget.  9 (2018)  5 - p. 6320-6335 , 2018
Link: https://doi.org/10.18632..
 
?
7

Abscopal Effect in Non-injected Tumors Achieved with Cytoki..:

Havunen, Riikka ; Santos, João M. ; Sorsa, Suvi...
Molecular Therapy - Oncolytics.  11 (2018)  - p. 109-121 , 2018
Link: https://doi.org/10.1016/..
 
?
8

A novelin silicoframework to improve MHC-I epitopes and bre..:

Capasso, Cristian ; Magarkar, Aniket ; Cervera-Carrascon, Victor...
OncoImmunology.  6 (2017)  9 - p. e1319028 , 2017
Link: https://doi.org/10.1080/..
 
?
9

Adenoviral production of interleukin‐2 at the tumor site re..:

Santos, Joao Manuel ; Havunen, Riikka ; Siurala, Mikko...
International Journal of Cancer.  141 (2017)  7 - p. 1458-1468 , 2017
Link: https://doi.org/10.1002/..
 
?
10

Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alp..:

Havunen, Riikka ; Siurala, Mikko ; Sorsa, Suvi...
Molecular Therapy - Oncolytics.  4 (2017)  - p. 77-86 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Intravenously usable fully serotype 3 oncolytic adenovirus ..:

Zafar, Sadia ; Parviainen, Suvi ; Siurala, Mikko...
OncoImmunology.  6 (2017)  2 - p. e1265717 , 2017
Link: https://doi.org/10.1080/..
 
?
12

Adenoviral Delivery of Tumor Necrosis Factor-α and Interleu..:

Siurala, Mikko ; Havunen, Riikka ; Saha, Dipongkor...
Molecular Therapy.  24 (2016)  8 - p. 1435-1443 , 2016
Link: https://doi.org/10.1038/..
 
?
13

405. IL-2 and TNF-a Coding Adenoviruses Enable Adoptive T C..:

Tähtinen, Siri ; Blattner, Carolin ; Vähä-Koskela, Markus...
Molecular Therapy.  24 (2016)  - p. S160-S161 , 2016
Link: https://doi.org/10.1016/..
 
?
14

652. Culture and Characterization of Tumor-Infiltrating Lym..:

Siurala, Mikko ; Vähä-Koskela, Markus ; Havunen, Riikka...
Molecular Therapy.  24 (2016)  - p. S259 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Corrigendum to "Adenoviral Delivery of Tumor Necrosis Facto..:

Siurala, Mikko ; Havunen, Riikka ; Saha, Dipongkor...
Molecular Therapy.  24 (2016)  11 - p. 2033 , 2016
Link: https://doi.org/10.1038/..
 
1-15